Investment Q&A

Q: Based on Portfolio Analytics my portfolio needs more international exposure and more industrial exposure. To that end I am looking at BASF SE the german chemical giant currently trading at a discount with a great dividend.
Should I be worried?

Q: Today ECN traded 6 x average daily volumes, is there any way we can know who is buying? Does this enhance your buy thesis on ECN?

Q: I note you recently indicated BNRE is only convertible into BN. I have only had BNRE for a few months. Hoped it would maybe pop 10-15% in 4-6 months. What are the advantages/disadvantages if converting BNRE to BN and would you recommend someone do that now or is there an advantage to wait until sometime next year (or not convert at all) ?

Q: how do I calculate the dividend yield per share when I know the yield % and number of shares? Google doesn't want to tell me!

Q: I checked out the 5i Profile page for Theratechnologies to see if there was any news regarding the large drop on December 1st but didn't see anything. I checked out Theratechnologies Investor Relations website and found the press release regarding the enrollment pause on the Phase 1 clinicial trial of TH1902. Why doesn't this press release show up in the News & Media section on TH's Profile in 5i?

Q: Looking to do an “in kind” transfer to my TFSA in Jan - which one would you choose and why?
Much appreciated. ram

Q: Hi Peter, Ryan, and 5i Team,

Sorry for yet another Brookfield question! In my RRIF, I hold these three Brookfield entities: BEP.UN, BN, and BAM.

As a retired investor who likes dividends, and is underweight in utilities (due to recently selling AQN) and is overweight in financials, would you endorse selling BN and BAM, and using the proceeds to buy more BEP.UN? Or is there a flaw in my thinking?

Thanks as always for your timely advice, and happy holidays to everyone at 5i.

Q: Selling BN:US for Tax Loss. Please suggest a proxy - I plan to buy it back after 30 business days.

Q: In several of your responses you have stated that "BN will be more growth oriented, BAM more income-oriented. " You also state "We like BAM at the current price, with an attractive and secure dividend." However, TD Webbroker shows BAM with no dividend whereas BN shows a yield of 1.77%. Am I missing something here? Thank you.
Dennis

Q: I am a “dividend + revenue” investor, considering the high volatility, recession risks, and inflation, these are my main "moves" in 2022 :

1) Sell most of smaller Cies stocks
2) Keep selected larger Cies stocks considered to be in a good financial and strategic position
3) Keep various REITS like data centers,real estate,etc.. (no shopping centers,since on line shopping is increasing)
4) “Accept to sell” (with high profit though) some excellent large Cies stocks in order to Increase the proportion of selected ETFs (dividend and/or dividend growth), including US ETF in RRSP
5) Keep a significant proportion of utilities ETF, and Canadian financial ETFs
6) No fixed income, no bonds,and no fixed income ETF ( I wish to equal or beat inflation if possible, plus the fact that fixed income products are not easy to trade and to manage ,except for experts)
7) Increase the proportion of covered call ETFs in order to better resist to volatility and to maintain stability of revenues
8) Keep closed-end funds and split-share corporations (in a small proportion)

What are the weak points, any adjustment suggested?

Thanks, you are always very helpfull to “refine “ researchs according to various strategies

Q: Any co. specific reasons for sharp drops on these companies besides tax loss selling. Pltr - 7.92% with $6.35 new low, Eglx 8.2%, Dir.un 2.9%, Stc 6.9%. When does tax loss selling finishes & will the bulk be done by friday this week? Txs for U usual great services & views

Q: I am selling one or all of TVE,AC,KXS for tax loss. All are down similar amount . Would you please list from first to last your preference for disposal.

Q: Hi 5i,
I wonder if you could give us some guidance. My wife holds the above in her RSP, with all being more or less a full position except for ENB at 2X, BCE, CM, and SU at 1.5X each and CHR and DXT at .5X each.
She has until the end of 2024 to convert to a RRIF and currently has $40K to contribute to her RSP and has the room for that contribution.
She would like to invest in some different names, or divest/reinvest in those she has, with an eye to maximizing value before the conversion to a RRIF and to continue thereafter. She's not asking for much - just safety, capital appreciation and income ...!
Based on this info, can you offer any thoughts on new names to add or which of the existing to either pull back on, or dump entirely if that extreme measure seems warranted?
Thank you 5i, and we wish you all an excellent holiday season.
Peter

Q: Hello,
Looking at doing some tax loss selling. Could you please rank the following: AT, BYL, KTOS, COIN, NVTA, NIU and U.
Thank you

Q: Which shares are BNRE exchangeable for, BN or BAM

Q: Hey guys
My question is about fixed income.
Either in my RRSP or taxable accounts I’m considering buying some GICs.
My thinking is I may be better buying triple b or better corporate bonds yielding close to the same yield but might have the capital appreciation and liquidity if rates start sliding, or hold till maturity!
Does this make sense or?
Thanks
Peter Snethlage

Q: Would you recommend CSX on a 2 year horizon. Or some of it`s competitors like CN or CP. Or not consider the space at all.

Q: What are your thoughts on the Magna purchase of Veoneer?

Q: I understand that you recommend VOO for S&P 500 coverage. I understand that this etfs weighting of companies is based on capital value. Which equivalent-weight etf would you recommend in its place?

Q: I hold the above within a RRIF. In total they are now worth $49K cost was $64K, current income approx $2K.

What do you think about selling them all and reinvesting in AAPL, MSFT, BRK and AMZN. Any alternatives you can suggest. I don't mind forgoing the income.